Cidara Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 3.37 M | $322.28 M | 0.00% | 21.65% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2025 | 3.02 M | $289.29 M | 20.81% | 19.43% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 1.58 M | $151.12 M | 3.28% | 10.15% |
| BVF INC/IL | 11/14/2025 | 1.41 M | $135.42 M | 79.83% | 9.10% |
| VIVO CAPITAL, LLC | 11/14/2025 | 1.31 M | $125.58 M | 0.00% | 8.44% |
| VANGUARD GROUP INC | 11/07/2025 | 1.23 M | $117.85 M | 27.31% | 7.92% |
| BLACKROCK, INC. | 11/12/2025 | 1.17 M | $111.60 M | 5.22% | 7.50% |
| DARWIN GLOBAL MANAGEMENT, LTD. | 11/14/2025 | 997.20 K | $94.99 M | 29.77% | 6.41% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 961.16 K | $92.04 M | 100.00% | 6.18% |
| VR ADVISER, LLC | 11/14/2025 | 946.79 K | $90.66 M | 48.15% | 6.09% |
| FMR LLC | 11/13/2025 | 775.53 K | $74.27 M | 613.34% | 4.99% |
| STATE STREET CORP | 11/14/2025 | 772.76 K | $74.00 M | 226.15% | 4.97% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 682.90 K | $65.36 M | 9.26% | 4.39% |
| CITADEL ADVISORS LLC | 11/14/2025 | 593.99 K | $56.88 M | 104.16% | 3.82% |
| COMMODORE CAPITAL LP | 11/14/2025 | 585.00 K | $56.02 M | -50.21% | 3.76% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2025 | 508.00 K | $48.65 M | 154.00% | 3.27% |
| FRED ALGER MANAGEMENT, LLC | 11/14/2025 | 502.88 K | $48.16 M | 100.00% | 3.23% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 493.81 K | $47.29 M | 6.70% | 3.18% |
| HOLOCENE ADVISORS, LP | 11/14/2025 | 487.23 K | $46.66 M | 100.00% | 3.13% |
| UBS GROUP AG | 11/13/2025 | 473.55 K | $45.35 M | 166.18% | 3.05% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 450.00 K | $43.09 M | -59.09% | 2.89% |
| MAVERICK CAPITAL LTD | 11/14/2025 | 417.55 K | $39.98 M | 100.00% | 2.69% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 405.40 K | $38.82 M | 10.70% | 2.61% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 404.11 K | $38.71 M | 8.63% | 2.60% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 400.00 K | $38.30 M | -20.00% | 2.57% |
| JENNISON ASSOCIATES LLC | 10/30/2025 | 396.02 K | $37.92 M | 704.71% | 2.55% |
| MORGAN STANLEY | 11/14/2025 | 378.18 K | $36.21 M | -57.19% | 2.43% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 375.00 K | $35.91 M | 97.37% | 2.41% |
| JEFFERIES FINANCIAL GROUP INC. | 11/13/2025 | 365.00 K | $34.95 M | -18.89% | 2.35% |
| SAMLYN CAPITAL, LLC | 11/14/2025 | 307.96 K | $29.49 M | 100.00% | 1.98% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 300.00 K | $28.73 M | 20.00% | 1.93% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 11/14/2025 | 292.66 K | $28.02 M | 62.03% | 1.88% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 277.70 K | $26.59 M | -40.21% | 1.79% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 270.00 K | $25.86 M | 5,626.49% | 1.74% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 249.40 K | $23.88 M | 85.94% | 1.60% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 241.77 K | $23.15 M | 433.42% | 1.56% |
| MARSHALL WACE, LLP | 11/13/2025 | 235.31 K | $22.53 M | -3.08% | 1.51% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 227.27 K | $21.76 M | 0.00% | 1.46% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 220.90 K | $21.15 M | 112.52% | 1.42% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 216.22 K | $20.71 M | -2.80% | 1.39% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2025 | 200.00 K | $19.15 M | 100.00% | 1.29% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 197.56 K | $18.92 M | 68.57% | 1.27% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 188.28 K | $18.03 M | 100.00% | 1.21% |
| ABRDN PLC | 11/07/2025 | 177.52 K | $17.00 M | -31.70% | 1.14% |
| ATIKA CAPITAL MANAGEMENT LLC | 11/13/2025 | 157.32 K | $15.06 M | 100.00% | 1.01% |
| INVESCO LTD. | 11/13/2025 | 157.17 K | $15.05 M | 25.31% | 1.01% |
| STEMPOINT CAPITAL LP | 11/14/2025 | 152.33 K | $14.59 M | -42.90% | 0.98% |
| JANE STREET GROUP, LLC | 11/14/2025 | 150.90 K | $14.45 M | 3,492.86% | 0.97% |
| NORTHERN TRUST CORP | 11/14/2025 | 150.17 K | $14.38 M | 3.44% | 0.97% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 145.42 K | $13.93 M | 194.18% | 0.94% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cidara Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 189 institutional investors and hedge funds held shares of Cidara Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 3.37 M
Bain Capital Life Sciences Investors, LLC: 3.02 M
Point72 Asset Management, L.P.: 1.58 M
BVF INC/IL: 1.41 M
Vivo Capital, LLC: 1.31 M
VANGUARD GROUP INC: 1.23 M
208.95% of Cidara Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 36.73 M shares in the last 24 months. This purchase volume represents approximately $8.09 B in transactions.